0% found this document useful (0 votes)
26 views23 pages

Visit Online 11-02-25

The document is a medical report for Miss Soumya Mishra, detailing various laboratory test results including Complete Blood Count (CBC), HbA1c, Glucose Fasting, and Liver Function Test (LFT). Most values are within normal ranges, with some parameters noted as outside the recognized scope of tests. The report includes interpretations for each test, indicating the patient's health status and potential medical conditions.

Uploaded by

Soumya
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
26 views23 pages

Visit Online 11-02-25

The document is a medical report for Miss Soumya Mishra, detailing various laboratory test results including Complete Blood Count (CBC), HbA1c, Glucose Fasting, and Liver Function Test (LFT). Most values are within normal ranges, with some parameters noted as outside the recognized scope of tests. The report includes interpretations for each test, indicating the patient's health status and potential medical conditions.

Uploaded by

Soumya
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 23

Patient NAME : Miss Soumya Mishra

DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report


Patient ID / UHID : 11332014/RCL10508291 Barcode NO : HR277437
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 03:07 PM.
Test Description Value(s) Unit(s) Reference Range

VH00GNP Female
Complete Blood Count (CBC)

RBC Parameters
Hemoglobin 13 g/dL 12.0 - 15.0
colorimetric
RBC Count 4.8 10^6/µl 3.8 - 4.8
Electrical impedance
PCV 39.2 % 36 - 46
Calculated
MCV 81.9 fl 83 - 101
Calculated
MCH 27.1 pg 27 - 32
Calculated
MCHC 33.1 g/dL 31.5 - 34.5
Calculated
RDW (CV) * 13.4 % 11.6 - 14.0
Calculated
RDW-SD * 42 fl 35.1 - 43.9
Calculated
WBC Parameters
TLC 7.4 10^3/µl 4 - 10
Electrical impedance and microscopy
Differential Leucocyte Count
Neutrophils 51 % 40-80
Lymphocytes 42 % 20-40
Monocytes 4 % 2-10
Eosinophils 3 % 1-6
Basophils 0 % <2
Absolute Leukocyte Counts
Neutrophils. 3.77 10^3/µl 2-7
Lymphocytes. 3.11 10^3/µl 1-3
Monocytes. 0.3 10^3/µl 0.2 - 1.0
Eosinophils. 0.22 10^3/µl 0.02 - 0.5
Basophils. 0 10^3/µl 0.02 - 0.5
Platelet Parameters
Platelet Count 338 10^3/µl 150 - 410
Electrical impedance and microscopy
Mean Platelet Volume (MPV) * 10.9 fL 9.3 - 12.1
Calculated
PCT * 0.4 % 0.17 - 0.32
Calculated

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 1 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : HR277437
Referred BY : Self Sample Type : Whole blood EDTA
Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 03:07 PM.
Test Description Value(s) Unit(s) Reference Range
P-LCR * 41.1 % 18 - 50
Calculated
P-LCC * 139 10^9/L 44 - 140
Calculated
Mentzer Index * 17.06 % > 13
Calculated

Interpretation:
CBC provides information about red cells, white cells and platelets. Results are useful in the diagnosis of anemia, infections, leukemias, clotting disorders and many
other medical conditions.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 2 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : HR277437
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 04:03 PM.
Test Description Value(s) Unit(s) Reference Range

HbA1C (Glycosylated Haemoglobin)

Glycosylated Hemoglobin (HbA1c) 5.5 % < 5.7


HPLC
Estimated Average Glucose * 111.15

Interpretation:
Interpretation For HbA1c% As per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years <5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5
Age > 19 years
Goal of therapy: < 7.0
Therapeutic goals for glycemic control
Age < 19 years
Goal of therapy: <7.5

Note:
1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still have a high
concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled.
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular disease. In patients with
significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 % may not be appropriate.

Comments :
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as compared to blood
and urinary glucose determinations ADA criteria for correlation between HbA1c & Mean plasma glucose levels.
HbA1c(%) Mean Plasma Glucose (mg/dL) HbA1c(%) Mean Plasma Glucose (mg/dL)
6 126 12 298
8 183 14 355
10 240 16 413

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 3 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : ZH381865
Referred BY : Self Sample Type : FLUORIDE F
....

Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 04:02 PM.
Test Description Value(s) Unit(s) Reference Range

Glucose Fasting

Glucose Fasting 92.6 mg/dL < 100 mg/dL: Normal


Hexokinase 100–125 mg/dL:
Prediabetes
>=126 mg/dL: Diabetes

Interpretation:
Status Fasting plasma glucose in mg/dL
Normal <100
Impaired fasting glucose 100 - 125
Diabetes =>126

Reference : American Diabetes Association

Comment :
Blood glucose determinations in commonly used as an aid in the diagnosis and treatment of diabetes. Elevated glucose levels
(hyperglycemia) may also occur with pancreatic neoplasm, hyperthyroidism, and adrenal cortical hyper function as well as other disorders.
Decreased glucose levels (hypoglycemia) may result from excessive insulin therapy insulinoma, or various liver diseases.

Note
1.The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL or a random / 2 hour plasma glucose value of > or = 200
mg/dL with symptoms of diabetes mellitus.
2.Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 4 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : ZH381864
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 06:58 PM.
Test Description Value(s) Unit(s) Reference Range

Liver Function Test (LFT)

Bilirubin Total 0.3 mg/dL 0 - 1.2


Colorimetric Diazo
Bilirubin Direct * 0.1 mg/dL 0 - 0.5
Bilirubin Indirect * 0.2 mg/dL 0.1 - 1.0
Calculation (T Bil - D Bil)
SGOT/AST 34.5 U/L up to 40
IFCC without P5P
SGPT/ALT 45.3 U/L up to 41
IFCC without P5P
SGOT/SGPT Ratio * 0.76 - -
Alkaline Phosphatase 119 U/L 35 - 104
IFCC
Total Protein 7.6 g/dL 6.0 - 7.8
Biuret
Albumin 4.4 g/dL 3.5 - 5.2
Colorimetric
Globulin * 3.2 g/dL 2.3 - 3.5
Calculation (T.P - Albumin)
Albumin :Globulin Ratio * 1.38 - 1.0 - 2.1
Calculation (Albumin/Globulin)
Gamma Glutamyl Transferase (GGT) * 41 U/L 5-40
ENZYMATIC

Interpretation:
The liver filters and processes blood as it circulates through the body. It metabolizes nutrients, detoxifies harmful substances, makes blood
clotting proteins, and performs many other vital functions. The cells in the liver contain proteins called enzymes that drive these chemical
reactions. When liver cells are damaged or destroyed, the enzymes in the cells leak out into the blood, where they can be measured by blood
tests Liver tests check the blood for two main liver enzymes. Aspartate aminotransferase (AST),SGOT: The AST enzyme is also found in
muscles and many other tissues besides the liver. Alanine aminotransferase (ALT), SGPT: ALT is almost exclusively found in the liver. If ALT
and AST are found together in elevated amounts in the blood, liver damage is most likely present. Alkaline Phosphatase and GGT: Another of
the liver's key functions is the production of bile, which helps digest fat. Bile flows through the liver in a system of small tubes (ducts), and is
eventually stored in the gallbladder, under the liver. When bile flow is slow or blocked, blood levels of certain liver enzymes rise: Alkaline
phosphatase Gamma-utamyl transpeptidase (GGT) Liver tests may check for any or all of these enzymes in the blood. Alkaline phosphatase
is by far the most commonly tested of the three. If alkaline phosphatase and GGT are elevated, a problem with bile flow is most likely present.
Bile flow problems can be due to a problem in the liver, the gallbladder, or the tubes connecting them. Proteins are important building blocks
of all cells and tissues. Proteins are necessary for your body's growth, development, and health. Blood contains two classes of protein,
albumin and globulin. Albumin proteins keep fluid from leaking out of blood vessels. Globulin proteins play an important role in your immune
system. Low total protein may

Indicate:
1.Bleeding
2.Liver disorder
3.Malnutrition
4.Agammaglobulinemia High Protein levels 'Hyperproteinemia: May be seen in dehydration due to inadequate water intake or to excessive
water loss (eg, severe vomiting, diarrhea, Addison's disease and diabetic acidosis) or as a result of increased production of proteins Low
albumin levels may be

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 5 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : ZH381864
Referred BY : Self Sample Type : Serum
Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 06:58 PM.
Test Description Value(s) Unit(s) Reference Range
Caused by:
1.A poor diet (malnutrition).
2.Kidney disease.
3.Liver disease. High albumin levels may be caused by: Severe dehydration.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 6 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : ZH381864
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 06:58 PM.
Test Description Value(s) Unit(s) Reference Range

Kidney Function Test (KFT)

Blood Urea 18.5 mg/dL 16.6 - 48.5


Urease
Bun * 8.64 mg/dL 6 - 20
Urease
Creatinine 0.5 mg/dL 0.50 - 0.90
Jaffe
eGFR (CKD-EPI) 130.06 ml/min/1.73 sq m Normal Or High: >= 90
Mild Or Decrease: 60-89
Mild To Moderate Decrease:
45-59
Mild To Severe Decrease:
30-44
Severe Decrease: 15-29
Kidney Failure: < 15
Bun/Creatinine Ratio * 17.28 12 - 20
Calculated
Urea / Creatinine Ratio * 37 25.68- 42.8
Calculated
Uric Acid 5.1 mg/dL 2.4 - 5.7
Enzymatic colorimetric
Calcium Serum 9.2 mg/dL 8.6 - 10.0
BAPTA
Phosphorus 3.7 mg/dL 2.5 - 4.5
Molybdate UV
Sodium 140 mmol/L 136 - 145
ISE-Indirect
Potassium 4.6 mmol/L 3.5 - 5.1
ISE-Indirect
Chloride 104.8 mmol/L 98 - 107
ISE-Indirect

Interpretation:
Kidney function tests is a collective term for a variety of individual tests and proceduresthat can be done toevaluate how well the kidneys are functioning. Many
conditions can affect the ability of the kidneys to carryout their vital functions. Somelead to a rapid (acute) decline in kidney functionothers lead to a gradual (chronic)
declineinfunction. Both result in a buildup of toxic waste subst done on urine samples, as well as on blood samples. A number of symptoms may indicate a problem with
your kidneys. These include : high blood pressure,blood in urine frequent urges to urinate,difficulty beginning urination,painful urination,swelling in the hands and feet
due to a buildup of fluids in the body. A single symptom may not mean something serious. However, when occurring simultaneously, these symptoms suggest that your
kidneys are not working properly. Kidney function tests can help determine the reason. Electrolytes are present in the human body and the balancing act of the
electrolytes in our bodies is essential for normal function of our cells and organs. There has to be a balance.Ionized calcium this test if you have signs of kidney or
parathyroid disease. The test may also be done to monitor progress and treatment of these diseases.
"eGFR test is applicable for patients aged 18 years or more."

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 7 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : ZH381864
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 06:58 PM.
Test Description Value(s) Unit(s) Reference Range

Lipid Profile

Total Cholesterol 175 mg/dL <200


Enzymatic - Cholesterol Oxidase
Triglycerides 247.2 mg/dL <150
Colorimetric - Lip/Glycerol Kinase
HDL Cholesterol 40.7 mg/dL >55
Enzymatic colorimetric
Non HDL Cholesterol * 134.3 mg/dL <130
Calculated
LDL Cholesterol * 84.86 mg/dL <100
Calculated
V.L.D.L Cholesterol * 49.44 mg/dL < 30
Calculated
Chol/HDL Ratio * 4.3 Ratio 3.5 - 5.0
Calculated
HDL/ LDL Ratio * 0.48 Ratio 0.5 - 3.0
Calculated
LDL/HDL Ratio * 2.09 Ratio -
Calculated

Interpretation:
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation. NCEP recommends of 3
different samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in single assays.

National Lipid Association Recommendations Total Cholesterol Triglyceride LDL Cholesterol Non HDL Cholesterol
(NLA-2014) (mg/dL) (mg/dL) (mg/dL) (mg/dL)
Optimal <200 <150 <100 <130

Above Optimal 100-129 130 - 159


Borderline High 200-239 150-199 130-159 160 - 189
High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220

HDL Cholesterol
Low High
<40 >=60

Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.

Risk Category A. CAD with > 1 feature of high risk group


B. CAD with >1 feature of very high risk group of recurrent ACS (within 1 year) despite LDL-C <or = 50 mg/dl
Extreme risk group
or poly vascular disease
1.Established ASCVD 2.Diabetes with 2 major risk factors of evidence of end organ
Very High Risk
damage 3. Familial Homozygous Hypercholesterolemia
1. Three major ASCVD risk factors 2. Diabetes with 1 major risk factor or no evidence

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 8 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : ZH381864
Referred BY : Self Sample Type : Serum
Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 06:58 PM.
Test Description Value(s) Unit(s) Reference Range
of end organ damage 3. CHD stage 3B or 4. 4 LDL >190 mg/dl 5. Extreme of a single
High Risk
risk factor 6. Coronary Artery Calcium - CAC > 300 AU 7. Lipoprotein a >/= 50 mg/dl
8. Non stenotic carotid plaque
Moderate Risk 2 major ASCVD risk factors
Low Risk 0-1 major ASCVD risk factors
Major ASCVD (Atherosclerotic cardiovascular disease) Risk Factors
1. Age >/=45 years in Males &
3. Current Cigarette smoking or tobacco use
>/= 55 years in Females
2. Family history of premature
4. High blood pressure
ASCVD
5. Low HDL

Newer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India
in 2020.

Risk Group Treatment Goals Consider Drug Therapy


LDL-C (mg/dl) Non-HDL (mg/dl) LDL-C (mg/dl) Non-HDL (mg/dl)

Extreme Risk Group Category A <50 (Optional goal <OR = 30) <80 (Optional goal <OR = 60) >OR = 50 >OR = 80
Extreme Risk Group Category B >OR = 30 >OR = 60 > 30 > 60
Very High Risk <50 <80 >OR = 50 >OR = 80
High Risk <70 <100 >OR = 70 >OR = 100
Moderate Risk <100 <130 >OR = 100 >OR = 130
Low Risk <100 <130 >OR = 130* >OR = 160

* After an adequate non-pharmacological intervention for at least 3 months.

References : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of
India. Current Vascular Pharmacology,2022,20,134-155.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 9 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : ZH381864
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 06:58 PM.
Test Description Value(s) Unit(s) Reference Range

Iron Studies

Iron 70.8 µg/dL 33 - 193


FerroZine
TIBC,(Total Iron Binding Capacity) 366.2 µg/dL 250 - 450
Method :Spectrophotometric Assay
UIBC 295.4 µg/dL 135 - 392
FerroZine
Transferrin Saturation 19.33 % 14-50
Derived from IRON and TIBC values

Interpretation:
Increased levels due to iron ingestion or ineffective erythropoiesis.Decreased levels due to infection, inflammation, malignancy, menstruation
and Fe deficiency.Needs to be taken into consideration with TIBC. Transferrin Saturation:- Low level Transferrin Saturation can indicate iron
deficiency, erythropoiesis, infection, or inflammation. High level Transferrin Saturation can indicate recent ingestion of dietary iron,ineffective
erythropoiesis,haemochromatosis or liver disease.High TIBC, UIBC, or transferrin usually indicates iron deficiency, but they are also
increased in pregnancy and with the use of oral contraceptives. Low TIBC, UIBC, or transferrin may occur if someone has:Hemochromatosis,
Certain types of anemia due to accumulated iron,Malnutrition,kidney disease that causes a loss of protein in urine.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 10 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : ZH381864
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 06:58 PM.
Test Description Value(s) Unit(s) Reference Range

C-Reactive Protein (CRP), Quantitative

CRP (Quantitative) 2.4 mg/L 0-5


Immunoturbidimetric

Interpretation:
Increased CRP level:
1. A high or increasing amount of CRP in the blood suggests the presence of inflammation but will not identify its location or the cause.
2. Suspected bacterial infection—a high CRP level can provide indication that patient has an infection.
3. Chronic inflammatory disease—high levels of CRP suggest a flare-up if you have a chronic inflammatory disease or that treatment has not
been effective.
If the CRP level is initially elevated and drops, it means that the inflammation or infection is subsiding and/or responding to treatment.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 11 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : ZH381864
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 07:37 PM.
Test Description Value(s) Unit(s) Reference Range

High Sensitivity C-Reactive Protein (Hs-CRP)

HIGHLY SENSITIVE C-REACTIVE PROTEIN (hs- 2.5 mg/L < 1.00


CRP)
immunoturbidimetric

Interpretation:
Cardio CRP In mg/L Cardiovascular Risk
<1 Low
1-3 Average
3-10 High
Persistent elevation may represent
>10
Non cardiovascular inflammation

Note: To assess vascular risk, it is recommended to test hsCRP levels 2 or more weeks apart and calculate the average

Comments:
High sensitivity C Reactive Protein (hsCRP) significantly improves cardiovascular risk assessment as it is a strongest predictor of future
coronary events. It reveals the risk of future Myocardial infarction and Stroke among healthy men and women, independent of traditional risk
factors. It identifies patients at risk of first Myocardial infarction even with low to moderate lipid levels. The risk of recurrent cardiovascular
events also correlates well with hsCRP levels. It is a powerful independent risk determinant in the prediction of incident Diabetes.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 12 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : ZH381864
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 07:37 PM.
Test Description Value(s) Unit(s) Reference Range

Rheumatoid Factor (RF), Quantitative

RHEUMATOID FACTOR, Quantitative 15.9 IU/mL <14


Immunoturbidimetry

Interpretation:
Approximately 85% of patients with Rheumatoid arthritis have detectable RA. It may also be seen in other medical conditions like Sjogren’s
syndrome and SLE.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 13 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : ZH381864
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 04:30 PM.
Test Description Value(s) Unit(s) Reference Range

Vitamin B12 / Cyanocobalamin

Vitamin - B12 440.4 pg/mL 187 - 883


CMIA

Interpretation:
Low Values are a sign of a vitamin B12 deficiency. People with this deficiency are likely to have or develop symptoms.
Causes of vitamin B12 deficiency include:Not enough vitamin B12 in diet (rare except with a strict vegetarian diet), Diseases that cause
malabsorption (for example, celiac disease and Crohn's disease), Lack of intrinsic factor, Above normal heat production (for example, with
hyperthyroidism), Pregnancy. Increased vitamin B12 levels are uncommon. Usually excess vitamin B12 is removed in the urine. Conditions
that can increase B12 levels include: Liver disease (such as cirrhosis or hepatitis), Myeloproliferative disorders (for example, polycythemia
vera and chronic myelocytic leukemia).

Vitamin B12: Low Levels can cause malabsorption, Lack of intrinsic factor, Above normal heat production (for example, with hyperthyroidism),
Pregnancy.High Level Liver disease, Myeloproliferative disorders (for example, polycythemia vera and chronic myelocytic leukemia).

1. Out of 140 healthy indian population, 91% of Vitamin B 12 concentrations was at lower level: 59.00 pg/ml and upper level: 700.00 pg/ml

"Patients on Biotin supplement may have interference in some immunoassays. Ref: Arch Pathol Lab Med—Vol 141, November 2017. With
individuals taking high dose Biotin (more than 5 mg per day) supplements, at least 8-hour wait time before blood draw is recommended."

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 14 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : ZH381864
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 04:30 PM.
Test Description Value(s) Unit(s) Reference Range

Vitamin D 25 Hydroxy

Vitamin D 25 - Hydroxy 22.5 ng/mL Deficiency : <30 ng/mL


CMIA

Interpretation:
25-Hydroxy vitamin D represents the main body reservoir and transport form. Mild to moderate deficiency is associated with Osteoporosis /
Secondary Hyperparathyroidism while severe deficiency causes Rickets in children and Osteomalacia in adults. Prevalence of Vitamin D
deficiency is approximately >50% specially in the elderly. This assay is useful for diagnosis of vitamin D deficiency and Hypervitaminosis D. It
is also used for differential diagnosis of causes of Rickets & Osteomalacia and for monitoring Vitamin D replacement therapy.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 15 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : ZH381864
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 04:30 PM.
Test Description Value(s) Unit(s) Reference Range

Thyroid Profile Total

Triiodothyronine (T3) 156 ng/dL 70 - 204


CMIA
Total Thyroxine (T4) 8.33 µg/dL 5.0- 12.5
CMIA
Thyroid Stimulating Hormone (Ultrasensitive) 2.94 mIU/L 0.54 - 5.30
CMIA

Interpretation:
Pregnancy Reference ranges TSH
1st Trimester 0.1 - 2.5
2nd Trimester 0.2 - 3.0
3rd Trimester 0.3 - 3.0
Note:
TSH levels are subject to circadian variation, reaching peak levels between 2-4 am. and at a minimum between 6-10 pm. The variation is of 50 %, hence time of
the day has influence on the measured serum TSH concentrations.

Clinical Use:
- Diagnose Hypothyroidism and Hyperthyroidism
- Monitor T4 replacement or T4 suppressive therapy
- Qunatify TSH levels in the subnormal range

Increased Levels : Primary hypothyroidism, Subclinical hypothyroidis, TSH dependent Hyperthyroidism, Thyroid hormone resistance
Decreased Levels: Grace disease, Autonomous thyroid hormone secretion, TSH deficiency

Primary malfunction of the thyroid gland may result in excessive (hyper) or below normal (hypo) release of T3 or T4. In addition as TSH directly affects thyroid
function, malfunction of the pituitary or the hypo - thalamus influences the thyroid gland activity. Disease in any portion of the thyroid-pitutary-hypothala- mus
system may influence the levels of T3 and T4 in the blood. In primary hypothyroidism, TSH levels are significantly elevated, while in secondary and tertiary
hypothyroidism, TSH levels may be low. In addition, in the Euthyroid Sick Syndrome, multiple alterations in serum thyroid function test findings have been
recognized in patients with a wide variety of non-thyroidal illnesses (NTI) without evidence of preexisting thyroid or hypothalami c-pitutary diseases. Thyroid
Binding Globulin (TBG) concentrations remain relatively constant in healthy individuals. However, pregnancy, excess estrogen's, androgen's, antibiotic steroids
and glucocorticoids are known to alter TBG levels and may cause false thyroid values for Total T3 and T4 tests.

TSH T4 T3 INTERPRETATION
High Normal Normal Mild (subclinical) hypothyroidism
Low or
High Low Hypothyroidism
Normal
Low Normal Normal Mild (subclinical) hyperthyroidism
High or High or
Low Hyperthyroidism
normal normal
Low or Low or
Low Nonthyroidal illness; pituitary (secondary) hypothyroidism
normal normal
Thyroid hormone resistance syndrome (a mutation in the thyroid hormone
Normal High High
receptor decreases thyroid hormone function)

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 16 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : ZH381864
Referred BY : Self Sample Type : Serum
Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 04:30 PM.
Test Description Value(s) Unit(s) Reference Range

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 17 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : ZH381864
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 04:30 PM.
Test Description Value(s) Unit(s) Reference Range

CA 125 (Ovarian Cancer Marker)

CA 125 OVARIAN CANCER MARKER, SERUM 23.17 U/mL <35


CMIA

Interpretation:
CA 125 is a surface antigen, identified as a 200 - 1000 kDa mucin-like glycoprotein associated with non-mucinous epithelial ovarian
malignancy. CA 125 is a useful tumor marker for evaluating therapy and monitoring disease status in patients under treatment for ovarian
cancer. Measured serially the levels of CA 125 correspond with disease progression or regression. The rate of change in CA 125 is also
highly prognostic. As a diagnostic tool however, the level of CA 125 alone is not sufficient to determine the presence of extent of disease.
Levels of CA 125 should not be interpreted as absolute evidence of the presence or the absence of malignant disease. Before treatment,
patients with confirmed ovarian carcinorma frequently have levels of CA 125 within the range observed in healthy regarding the histological
grade or diameter of the tumor mass.

Elevated levels of CA 125 can be observed in patients with nonmalignant diseases. Patients with certain benign conditions, such as hepatic
cirrhosis, acute pancreatitis, endometriosis, pelvic inflammatory disease, menstruation and first trimester pregnancy show elevated levels of
CA 125. Elevated levels are also found in 1 to 2 % of healthy donors. Measurements of CA 125 sholud always be used in conjunction with
other diagnostic procedures, including information from the patients clinical evaluation. The concentration of CA 125 in a given specimen
determined with assays from different manufacturers can vary due to differences in assay methods, calibration, and reagent specificity. Values
obtained with different assay methods cannot be used interchangeably. Heterophilic antibodies in human serum can react with reagent
immunoglobulins, interfering with in vitro immunoassays. Patients routinely exposed to animal or to animal serum products can be prone to
this interference and anomalous values may be observed

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 18 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : ZH381864
Referred BY : Self Sample Type : Serum
....

Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 10, 2025, 09:58 AM.
Test Description Value(s) Unit(s) Reference Range

Apolipoproteins A1 & B

Apolipoprotein A-1 (APO-A) 117 mg/dL 104 - 202


Tina-quant
Apolipoprotein B (APO-B) 97 mg/dL 66 - 144
Tina-quant
Apo B / Apo A1 Ratio 0.83 0.35 - 0.98

Interpretation:
The Apo A1 and Apo B blood tests are crucial for assessing lipid metabolism and cardiovascular risk. High Apo A1 and low Apo B levels are
associated with a lower risk of cardiovascular disease, while low Apo A1 and high Apo B levels indicate a higher risk. Management involves
lifestyle modifications, medications, and regular monitoring to maintain optimal lipid levels and reduce cardiovascular risk. Consulting
healthcare providers for accurate interpretation and tailored treatment plans is essential for effective management.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., H-55, Sector-63, Noida, Uttar Pradesh - 201301

Page 19 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : YB743528
Referred BY : Self Sample Type : Spot Urine
....

Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 03:44 PM.
Test Description Value(s) Unit(s) Reference Range

Urine Routine and Microscopic Examination

Physical Examination
Volume * 15 mL -
Colour * Pale yellow - Pale yellow
Transparency * Slightly Hazy - Clear
Deposit * Absent - Absent
Chemical Examination
Reaction (pH) 6.0 - 4.5 - 8.0
Double Indicator
Specific Gravity 1.010 - 1.010 - 1.030
Ion Exchange
Urine Glucose (sugar) Negative - Negative
Oxidase / Peroxidase
Urine Protein (Albumin) Negative - Negative
Acid / Base Colour Excahnge
Urine Ketones (Acetone) Negative - Negative
Legals Test
Blood Positive(Trace) - Negative
Peroxidase Hemoglobin
Leucocyte esterase Positive(Trace) - Negative
Enzymatic Reaction
Bilirubin Urine Negative - Negative
Coupling Reaction
Nitrite Negative - Negative
Griless Test
Urobilinogen Normal - Normal
Ehrlichs Test
Microscopic Examination
Pus Cells (WBCs) * 2-3 /hpf 0-5
Epithelial Cells * 3-5 /hpf 0-4
Red blood Cells * 1-2 /hpf Absent
Crystals * Absent - Absent
Cast * Absent - Absent
Yeast Cells * Absent - Absent
Amorphous deposits * Absent - Absent
Bacteria * Absent - Absent
Protozoa * Absent - Absent

Interpretation:
URINALYSIS- Routine urine analysis assists in screening and diagnosis of various metabolic, urological, kidney and liver disorders.

Protein: Elevated proteins can be an early sign of kidney disease. Urinary protein excretion can also be temporarily elevated by strenuous
exercise, orthostatic proteinuria, dehydration, urinary tract infections and acute illness with fever

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 20 of 21
Patient NAME : Miss Soumya Mishra
DOB/Age/Gender : 29 Y 19 D/Female Report STATUS : Final Report
Patient ID / UHID : 11332014/RCL10508291 Barcode NO : YB743528
Referred BY : Self Sample Type : Spot Urine
Sample Collected : Feb 09, 2025, 07:59 AM Report Date : Feb 09, 2025, 03:44 PM.
Test Description Value(s) Unit(s) Reference Range

Glucose: Uncontrolled diabetes mellitus can lead to presence of glucose in urine. Other causes include pregnancy, hormonal disturbances,
liver disease and certain medications.

Ketones: Uncontrolled diabetes mellitus can lead to presence of ketones in urine. Ketones can also be seen in starvation, frequent vomiting,
pregnancy and strenuous exercise.

Blood: Occult blood can occur in urine as intact erythrocytes or haemoglobin, which can occur in various urological, nephrological and
bleeding disorders.

Leukocytes: An increase in leukocytes is an indication of inflammation in urinary tract or kidneys. Most common cause is bacterial urinary tract
infection.

Nitrite: Many bacteria give positive results when their number is high. Nitrite concentration during infection increases with length of time the
urine specimen is retained in bladder prior to collection.

pH: The kidneys play an important role in maintaining acid base balance of the body. Conditions of the body producing acidosis/ alkalosis or
ingestion of certain type of food can affect the pH of urine.

Specific gravity: Specific gravity gives an indication of how concentrated the urine is. Increased specific gravity is seen in conditions like
dehydration, glycosuria and proteinuria while decreased specific gravity is seen in excessive fluid intake, renal failure and diabetes insipidus.

Bilirubin: In certain liver diseases such as biliary obstruction or hepatitis, bilirubin gets excreted in urine.

Urobilinogen: Positive results are seen in liver diseases like hepatitis and cirrhosis and in cases of haemolytic anaemia.

*** End Of Report ***

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .


Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 1st Floor, Shop No.1, Nile Complex, Old Hazaribagh Road, Kantatoli,
Ranchi, Jharkhand-834001

Page 21 of 21
ADPL HBA1c Graph Report

Name : Sample Id : HR277437


Sample Type : Whole Blood EDTA
Total Area :
11.091

Peak Name Retention Time(s) Absorbance Area Result (Area %)

HbA0 69 0.2253 10.084 91


HbA1c 38 0.0053 0.602 5.5
La1c 36 0.0056 0.138 1.2
HbF 22 0.0017 0.098 0.8
Hba1b 16 0.0039 0.124 1.1
Hba1a 12 0.0015 0.045 0.4
HOW WAS YOUR EXPERIENCE?
We value your feedback, please scan with your phone camera
and rate overall experience.

How likely are you to recommend Redcliffe Labs to your family & friends

Not Likely Very Likely

Scan with your phone camera

You might also like